tetano
Editor, Senior Moderator
Obstet Gynecol
. 2023 Aug 3.
doi: 10.1097/AOG.0000000000005279. Online ahead of print. Risk of Miscarriage in Relation to Seasonal Influenza Vaccination Before or During Pregnancy
Annette K Regan[SUP] 1 [/SUP], Amelia K Wesselink, Tanran R Wang, David A Savitz, Jennifer J Yland, Kenneth J Rothman, Elizabeth E Hatch, Lauren A Wise
Affiliations
Objective: To evaluate the association between seasonal influenza vaccination and miscarriage using data from an ongoing, prospective cohort study.
Methods: We analyzed 2013-2022 data from PRESTO (Pregnancy Study Online), a prospective prepregnancy cohort study of female pregnancy planners and their male partners in the United States and Canada. Female participants completed a baseline questionnaire and then follow-up questionnaires every 8 weeks until pregnancy, during early and late pregnancy, and during the postpartum period. Vaccine information was self-reported on all questionnaires. Miscarriage was identified from self-reported information during follow-up. Male partners were invited to complete a baseline questionnaire only. We used Cox proportional hazard models to estimate the hazard ratio (HR) and 95% CI for the association between vaccination less than 3 months before pregnancy detection through the 19th week of pregnancy and miscarriage, with gestational weeks as the time scale. We modeled vaccination as a time-varying exposure and used propensity-score fine stratification to control for confounding from seasonal and female partner factors.
Results: Of 6,946 pregnancies, 23.3% of female partners reported exposure to influenza vaccine before or during pregnancy: 3.2% during pregnancy (gestational age 4-19 weeks) and 20.1% during the 3 months before pregnancy detection. The miscarriage rate was 16.2% in unvaccinated and 17.0% among vaccinated participants. Compared with no vaccine exposure, influenza vaccination was not associated with increased rate of miscarriage when administered before (HR 0.99, 95% CI 0.81-1.20) or during (HR 0.83, 95% CI 0.47-1.47) pregnancy. Of the 1,135 couples with male partner vaccination data available, 10.8% reported vaccination less than 3 months before pregnancy. The HR for the association between male partner vaccination and miscarriage was 1.17 (95% CI 0.73-1.90).
Conclusion: Influenza vaccination before or during pregnancy was not associated with miscarriage.
. 2023 Aug 3.
doi: 10.1097/AOG.0000000000005279. Online ahead of print. Risk of Miscarriage in Relation to Seasonal Influenza Vaccination Before or During Pregnancy
Annette K Regan[SUP] 1 [/SUP], Amelia K Wesselink, Tanran R Wang, David A Savitz, Jennifer J Yland, Kenneth J Rothman, Elizabeth E Hatch, Lauren A Wise
Affiliations
- PMID: 37535959
- DOI: 10.1097/AOG.0000000000005279
Objective: To evaluate the association between seasonal influenza vaccination and miscarriage using data from an ongoing, prospective cohort study.
Methods: We analyzed 2013-2022 data from PRESTO (Pregnancy Study Online), a prospective prepregnancy cohort study of female pregnancy planners and their male partners in the United States and Canada. Female participants completed a baseline questionnaire and then follow-up questionnaires every 8 weeks until pregnancy, during early and late pregnancy, and during the postpartum period. Vaccine information was self-reported on all questionnaires. Miscarriage was identified from self-reported information during follow-up. Male partners were invited to complete a baseline questionnaire only. We used Cox proportional hazard models to estimate the hazard ratio (HR) and 95% CI for the association between vaccination less than 3 months before pregnancy detection through the 19th week of pregnancy and miscarriage, with gestational weeks as the time scale. We modeled vaccination as a time-varying exposure and used propensity-score fine stratification to control for confounding from seasonal and female partner factors.
Results: Of 6,946 pregnancies, 23.3% of female partners reported exposure to influenza vaccine before or during pregnancy: 3.2% during pregnancy (gestational age 4-19 weeks) and 20.1% during the 3 months before pregnancy detection. The miscarriage rate was 16.2% in unvaccinated and 17.0% among vaccinated participants. Compared with no vaccine exposure, influenza vaccination was not associated with increased rate of miscarriage when administered before (HR 0.99, 95% CI 0.81-1.20) or during (HR 0.83, 95% CI 0.47-1.47) pregnancy. Of the 1,135 couples with male partner vaccination data available, 10.8% reported vaccination less than 3 months before pregnancy. The HR for the association between male partner vaccination and miscarriage was 1.17 (95% CI 0.73-1.90).
Conclusion: Influenza vaccination before or during pregnancy was not associated with miscarriage.